We study how microbes interact with the immune system to modulate the development and therapy success in cancer and chronic inflammatory disorders.
We are particularly interested in colorectal cancer and inflammatory bowel disease and pursue highly translational bedside to bench to bedside approaches.
It is our goal to identify specific microbes or their products that can be used to either prevent/stop disease development or represent novel therapeutic options.